Core Laboratories
CLB
164 hedge funds and large institutions have $1.13B invested in Core Laboratories in 2023 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 48 reducing their positions, and 31 closing their positions.
1,002% more call options, than puts
Call options by funds: $1.46M | Put options by funds: $132K
15% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 48
12% more capital invested
Capital invested by funds: $1.02B → $1.13B (+$119M)
5.81% more ownership
Funds ownership: 98.7% → 104.51% (+5.8%)
3% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 31
1% more funds holding
Funds holding: 163 → 164 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$49.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$12.8M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.5M |
| 4 |
WI
Wintrust Investments
Chicago,
Illinois
|
+$8.01M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$19.3M |
| 2 |
SEI Investments
Oaks,
Pennsylvania
|
-$10.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$7.4M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$6.7M |
| 5 |
BBL
Beck Bode LLC
Dedham,
Massachusetts
|
-$4.84M |
CLB Hedge Fund Activity: Q2 2023 in Review
164 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2023, worth a combined $1.13B — up 12% from $1.02B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new CLB positions and 31 closed out — a net gain of 1 holder — while 55 added to existing stakes and 48 trimmed.
The largest buyer was BlackRock, adding an estimated $49.1M. The largest seller was Fred Alger Management, cutting an estimated $19.3M.
- 164 institutional investors held Core Laboratories (CLB) as of Q2 2023, up from 163 in Q1 2023.
- Funds reported $1.13B of Core Laboratories stock for Q2 2023, up 12% quarter-over-quarter.
- 32 funds opened new Core Laboratories positions in Q2 2023 and 31 closed out, a net change of +1 holder.
- The largest Core Laboratories buyer in Q2 2023 was BlackRock, an estimated $49.1M added.
- The largest Core Laboratories seller in Q2 2023 was Fred Alger Management, an estimated $19.3M sold.
Based on aggregated 13F filings for Q2 2023.